AzTrials
AzTrials

OstomyAI-MNINCT07805226

Artificial Intelligence-Supported Nursing Program for Sleep Quality in People With an Ostomy

A study testing AI-MNI: Artificial Intelligence-Supported Multimodal Nursing Intervention in people with Ostomy and Sleep Quality, run by Koç University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Individuals living with an intestinal or urinary stoma frequently report disturbed sleep. Night-time pouch filling and leakage, odour and gas concerns, restricted sleeping positions, peristomal skin problems and the need for night-time pouch emptying interrupt sleep, while anxiety, depressive symptoms, altered body… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ostomy, Sleep Quality, Quality of Life
What is being tested?
AI-MNI: Artificial Intelligence-Supported Multimodal Nursing Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2026to 15 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or older
  • Living with a colostomy, ileostomy or urostomy for at least three months
  • Pittsburgh Sleep Quality Index global score greater than 5, indicating poor sleep quality
  • Owns a smartphone with internet access and is able to use the digital modules and the chatbot
  • Cognitively able to complete self-report questionnaires and to participate actively in the intervention
  • Literate and able to communicate in Turkish
  • Provides written informed consent

Who cannot join

  • Clinically diagnosed and/or currently treated primary sleep disorder
  • Sensory, cognitive or communication impairment that would prevent compliance with study procedures
  • Regular use of hypnotics, sedatives, antidepressants or antipsychotics
  • Any clinical or social condition that would prevent regular participation in the intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayişe Karadağ, Prof contact

akaradag@ku.edu.tr

Turkey (Türkiye)1 site
  • Koc University Hospital

    Istanbul, Zeytinburnu, 34010

    Ayişe Karadağ, Prof, +90 850 250 8250 ext. 29712, akaradag@ku.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of an Artificial Intelligence-Supported Multimodal Nursing Intervention on Sleep Quality in Individuals With an Ostomy: A Randomized Controlled Trial

Individuals living with an intestinal or urinary stoma frequently report disturbed sleep. Night-time pouch filling and leakage, odour and gas concerns, restricted sleeping positions, peristomal skin problems and the need for night-time pouch emptying interrupt sleep, while anxiety, depressive symptoms, altered body image and social withdrawal add to this burden. Poor sleep in this population has been associated with reduced quality of life and impaired daytime functioning; however, most of the available evidence is cross-sectional and based exclusively on self-reported measures. Nursing interventions that specifically target sleep in people with a stoma are few, generally consist of a single component, and have rarely been tested in randomised designs or alongside objective sleep measurement.

This trial evaluates an Artificial Intelligence-Supported Multimodal Nursing Intervention (AI-MNI) developed to improve sleep quality in adults living with a stoma. The intervention was designed in line with the Medical Research Council framework for complex interventions and is delivered over four weeks through the institutional web-based learning management system. It comprises five structured modules: stoma care and night-time comfort; sleep hygiene and night routine; psychological wellbeing and relaxation techniques; body image, self-esteem and sexual health; and physical activity and daily energy management. Each module combines written material, video, visual guides, checklists and short knowledge checks. A rule-based chatbot embedded in the platform supports participants by prioritising content, suggesting review of relevant material and responding to questions within a pre-approved educational content set; it does not provide diagnosis, treatment advice or clinical decision support. All content was evaluated for content validity by an expert panel before implementation.

The study is a two-arm, parallel-group randomised controlled trial conducted in the stomatherapy unit of a university hospital. Forty-two adults (21 per group) with a colostomy, ileostomy or urostomy of at least three months' duration and a Pittsburgh Sleep Quality Index (PSQI) global score greater than 5 will be allocated in a 1:1 ratio using permuted block randomisation with variable block sizes, stratified by sex and stoma type. Allocation is concealed through a central, password-protected web-based system, and statistical analyses are performed by a statistician blinded to group codes. The intervention group receives AI-MNI in addition to standard care; the control group receives standard care alone and is offered access to the programme after the final assessment (delayed-access design). Assessments are conducted at baseline (T0), at the first month (T1) and at the third month (T2). The primary outcome is the change in PSQI global score from baseline to the first month, with the third-month assessment used to examine whether any improvement is maintained. Secondary outcomes are objective sleep parameters (total sleep time, sleep efficiency, sleep stage indicators and sleep onset latency) recorded with a consumer wrist-worn device on three consecutive nights at each assessment point, and stoma-specific quality of life. Module completion, session duration and level of interaction are reported as process outcomes. Analyses follow the intention-to-treat principle and are based primarily on linear mixed-effects models.

Being tested
AI-MNI: Artificial Intelligence-Supported Multimodal Nursing Intervention
Keywords
Patient Education, Artificial Intelligence, Digital Health, Chatbot, Nursing Intervention, Sleep, Randomized Controlled Trial
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI-MNI: Artificial Intelligence-Supported Multimodal Nursing InterventionBehavioural

    Also called Multimodal digital nursing intervention for sleep, AI-MNI

    Four-week, module-based digital nursing intervention delivered through the institutional web-based learning management system, in addition to standard stomatherapy care. Five modules address stoma care and night-time comfort; sleep hygiene and night routine; psychological wellbeing and relaxation techniques; body image, self-esteem and sexual health; and physical activity and daily energy management. Each module combines written material, video, visual guides, checklists and short knowledge checks, and all modules are available throughout the four-week period. A rule-based chatbot embedded in the platform prioritises content, suggests review of relevant material and answers questions within a pre-approved educational content set; it does not provide diagnosis, treatment advice or clinical decision support. Content validity was established with an expert panel, and platform use (module completion, session duration, interaction) is recorded as a process outcome.

Study groups in NCT07805226
Study groupRoleWhat they receive
AI-MNI (intervention group)ExperimentalParticipants receive the Artificial Intelligence-Supported Multimodal Nursing Intervention (AI-MNI) in addition to standard stomatherapy care. The intervention is delivered over four weeks through the institutional web-based learning management system and comprises five modules: stoma care and night-time comfort; sleep hygiene and night routine; psychological wellbeing and relaxation techniques; body image, self-esteem and sexual health; and physical activity and daily energy management. Modules combine written material, video, visual guides, checklists and short knowledge checks. A rule-based chatbot embedded in the platform prioritises content, suggests review of relevant material and answers questions within a pre-approved educational content set; it does not provide diagnosis, treatment advice or clinical decision support.
Receives: Behavioral: AI-MNI: Artificial Intelligence-Supported Multimodal Nursing Intervention
Standard stomatherapy care (control group)No interventionParticipants receive standard stomatherapy care delivered by the certified stoma and wound care nurses of the unit, including standard ostomy education, counselling and scheduled follow-up visits. They have no access to the AI-MNI modules or the chatbot during the study period, and are offered access to the programme after the final (third-month) assessment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in sleep quality (Pittsburgh Sleep Quality Index)

    PSQI global score, range 0-21; higher scores indicate poorer sleep quality. Change from baseline to the end of the first month.

    Measured: Baseline (T0) and 1 month (T1)

Secondary outcomes (6)
  1. Sleep quality at 3 months (Pittsburgh Sleep Quality Index)

    PSQI global score, range 0-21; higher scores indicate poorer sleep quality. Change from baseline to the third month, assessing maintenance of the effect.

    Measured: Baseline (T0) and 3 months (T2)

  2. Total sleep time measured with a wrist-worn device

    Total sleep time in minutes per night, recorded with a consumer wrist-worn device over three consecutive nights at each assessment point and averaged across the three nights. Higher values indicate longer sleep duration.

    Measured: Baseline (T0), 1 month (T1) and 3 months (T2)

  3. Sleep efficiency measured with a wrist-worn device

    Sleep efficiency, calculated as total sleep time divided by time in bed and expressed as a percentage, recorded with a consumer wrist-worn device over three consecutive nights at each assessment point and averaged across the three nights. Higher values indicate better sleep continuity.

    Measured: Baseline (T0), 1 month (T1) and 3 months (T2)

  4. Sleep onset latency measured with a wrist-worn device

    Sleep onset latency in minutes, defined as the interval between bedtime and sleep onset, recorded with a consumer wrist-worn device over three consecutive nights at each assessment point and averaged across the three nights. Lower values indicate faster sleep onset.

    Measured: Baseline (T0), 1 month (T1) and 3 months (T2)

  5. Proportion of total sleep time spent in deep sleep

    Time spent in device-derived deep sleep, expressed as a percentage of total sleep time, recorded with a consumer wrist-worn device over three consecutive nights at each assessment point and averaged across the three nights. Higher values indicate a greater proportion of deep sleep. Device-derived sleep stage estimates are reported as complementary indicators and not as a substitute for polysomnography.

    Measured: Baseline (T0), 1 month (T1) and 3 months (T2)

  6. Stoma-specific quality of life (Stoma Quality of Life Scale)

    Turkish version of the Stoma Quality of Life Scale; scores converted to a 0-100 range, higher scores indicate better quality of life.

    Measured: Baseline (T0), 1 month (T1) and 3 months (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion15 Mar 2027 (estimated)
  4. Study completion15 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm, parallel-group design. Participants are randomised 1:1 to the intervention group (AI-MNI in addition to standard stomatherapy care) or the control group (standard stomatherapy care alone). Control group participants are offered access to the digital programme after the final assessment (delayed-access design).
Masking
None (open label)
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07805226
Sponsor's protocol ID
2025.450.IRB2.204
Other IDs
126S509
Acronym
AI-MNI
Status last verified
Sep 2026
First submitted
31 Aug 2026
Last updated
4 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared. Participants provided informed consent on the basis that their coded data would be accessed only by the research team, would not be shared with third parties, and would be securely destroyed after the institutionally required retention period. Data are processed in accordance with the Turkish Personal Data Protection Law (No. 6698) and the conditions of the approving ethics committee. Aggregate results will be disseminated through peer-reviewed publication.

Publications

  • Karadağ A, Öztürk D, Çelik B. Adaptation of Quality of Life Scale for the ostomy patients into Turkish. Turkish Journal of Colorectal Disease. 2011;21(4):173-181.

  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PubMed 2748771
  • Robbins R, Weaver MD, Sullivan JP, Quan SF, Gilmore K, Shaw S, Benz A, Qadri S, Barger LK, Czeisler CA, Duffy JF. Accuracy of Three Commercial Wearable Devices for Sleep Tracking in Healthy Adults. Sensors (Basel). 2024 Oct 10;24(20):6532. doi: 10.3390/s24206532.

    PubMed 39460013
  • Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.

    PubMed 34593508
  • Harputlu D, Ozturk FO, Aydin D, Akyol C, Tezel A. Effect of Laughter Yoga on Sleep and Quality of Life in Individuals With Fecal Ostomies: A Randomized Controlled Trial. J Wound Ostomy Continence Nurs. 2023 Jul-Aug 01;50(4):307-312. doi: 10.1097/WON.0000000000000988.

    PubMed 37467409
  • Temiz Z, Cavdar I, Ozbas A, Altunsoy M, Akyuz N, Kutlu FY. Sleep Quality and Factors Affecting Sleep in Individuals With an Intestinal Ostomy: A Descriptive Cross-Sectional Study. Wound Manag Prev. 2022 May;68(5):28-36. doi: 10.25270/wmp.2022.5.2836.

    PubMed 35617011
  • Avci Isik S, Balanuye B, Budak Erturk E, Karahan A, Ustundag C, Ugurlu Z, Oren Hin A, Aydin D, Gocmen Baykara Z, Acarlar H, Akar E, Kosker Y, Koc MA. Sleep Problems in Individuals With Intestinal Stomas and Determining the Quality of Sleep: A Multicenter Study. J Wound Ostomy Continence Nurs. 2023 Jan-Feb 01;50(1):39-46. doi: 10.1097/WON.0000000000000939.

    PubMed 36640163

Questions about this trial

What is this clinical trial studying?

A study testing AI-MNI: Artificial Intelligence-Supported Multimodal Nursing Intervention in people with Ostomy and Sleep Quality, run by Koç University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Havanur Kılıç, RN, MSc (+90 850 250 8250 ext. 2677, havvanurkilic16@ku.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in sleep quality (Pittsburgh Sleep Quality Index) (time frame: Baseline (T0) and 1 month (T1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07805226, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in